BD Moves The Needle To High Growth Segments

Exploiting The Trend To Pharmacy Automation And Remote Patient Care

Becton Dickinson is investing in high-growth segments and is on a mission to simplify its business. CEO Tom Polen’s 2025 strategy targets 25% operating margin from both innovations and durable core business combined, as senior BD executives told In Vivo during a break at J.P. Morgan 2024.

Added Value
• Source: Shutterstock

More from Leadership

More from Medtech Insight